SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8+ T cell activation.
Liu W, You D, Lin J, Zou H, Zhang L, Luo S, Yuan Y, Wang Z, Qi J, Wang W, Ye X, Yang X, Deng Y, Teng F, Zheng X, Lin Y, Huang Z, Huang Y, Yang Z, Zhou X, Zhang Y, Chen R, Xu L, Li J, Yang W, Zhang H.
Liu W, et al. Among authors: zhang l, zhang h, zhang y.
Cell Metab. 2024 Nov 5;36(11):2489. doi: 10.1016/j.cmet.2024.10.009. Epub 2024 Oct 16.
Cell Metab. 2024.
PMID: 39419036
No abstract available.